Sanofi India is currently trading at Rs. 4369.50, up by 73.00 points or 1.70% from its previous closing of Rs. 4296.50 on the BSE.
The scrip opened at Rs. 4356.10 and has touched a high and low of Rs. 4399.00 and Rs. 4356.10 respectively. So far 93 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 4651.10 on 13-Nov-2015 and a 52 week low of Rs. 3090.00 on 27-Apr-2015.
Last one week high and low of the scrip stood at Rs. 4410.00 and Rs. 4252.00 respectively. The current market cap of the company is Rs. 10098.93 crore.
The promoters holding in the company stood at 60.40% while Institutions and Non-Institutions held 29.32% and 10.28% respectively.
Sanofi’s vaccines division -- Sanofi Pasteur -- has launched ShanIPV, an injectable inactivated polio vaccine (IPV) manufactured by its arm Shantha Biotechnics in Hyderabad.
ShanIPV is a ‘made in India’ vaccine, manufactured in Hyderabad through technology transfer from Sanofi Pasteur. It is currently approved for use in the Indian market.
Both Sanofi Pasteur and its affiliate Shantha will provide the majority of vaccine doses needed till the end of 2016. All vaccines (both Imovax Polio of Sanofi Pasteur and ShanIPV of Shantha) will be delivered to India through UNICEF.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |